No Data
No Data
Director Makes Bold Move With Major Stock Purchase in Ionis Pharmaceuticals
Ionis Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $38 to $78
Ionis Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 13 Experts
Ionis Pharmaceuticals Lifts Revenue Forecast After Strong Q1, Oppenheimer Says